CEP55_HUMAN - dbPTM
CEP55_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CEP55_HUMAN
UniProt AC Q53EZ4
Protein Name Centrosomal protein of 55 kDa {ECO:0000312|HGNC:HGNC:1161}
Gene Name CEP55 {ECO:0000312|HGNC:HGNC:1161}
Organism Homo sapiens (Human).
Sequence Length 464
Subcellular Localization Cytoplasm . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Cleavage furrow . Midbody, Midbody ring . Present at the centrosomes at interphase. A sma
Protein Description Plays a role in mitotic exit and cytokinesis. [PubMed: 16198290]
Protein Sequence MSSRSTKDLIKSKWGSKPSNSKSETTLEKLKGEIAHLKTSVDEITSGKGKLTDKERHRLLEKIRVLEAEKEKNAYQLTEKDKEIQRLRDQLKARYSTTTLLEQLEETTREGERREQVLKALSEEKDVLKQQLSAATSRIAELESKTNTLRLSQTVAPNCFNSSINNIHEMEIQLKDALEKNQQWLVYDQQREVYVKGLLAKIFELEKKTETAAHSLPQQTKKPESEGYLQEEKQKCYNDLLASAKKDLEVERQTITQLSFELSEFRRKYEETQKEVHNLNQLLYSQRRADVQHLEDDRHKTEKIQKLREENDIARGKLEEEKKRSEELLSQVQFLYTSLLKQQEEQTRVALLEQQMQACTLDFENEKLDRQHVQHQLHVILKELRKARNQITQLESLKQLHEFAITEPLVTFQGETENREKVAASPKSPTAALNESLVECPKCNIQYPATEHRDLLVHVEYCSK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Phosphorylation---MSSRSTKDLIKS
---CCCCCHHHHHHH
41.5824719451
6Ubiquitination--MSSRSTKDLIKSK
--CCCCCHHHHHHHH
27.7122817900
11UbiquitinationRSTKDLIKSKWGSKP
CCHHHHHHHHCCCCC
53.9621890473
13UbiquitinationTKDLIKSKWGSKPSN
HHHHHHHHCCCCCCC
51.0429967540
16PhosphorylationLIKSKWGSKPSNSKS
HHHHHCCCCCCCCCC
40.0327470641
17UbiquitinationIKSKWGSKPSNSKSE
HHHHCCCCCCCCCCH
48.8329967540
19PhosphorylationSKWGSKPSNSKSETT
HHCCCCCCCCCCHHH
58.4325002506
21PhosphorylationWGSKPSNSKSETTLE
CCCCCCCCCCHHHHH
41.7325002506
22UbiquitinationGSKPSNSKSETTLEK
CCCCCCCCCHHHHHH
57.4733845483
23PhosphorylationSKPSNSKSETTLEKL
CCCCCCCCHHHHHHH
39.7430576142
25PhosphorylationPSNSKSETTLEKLKG
CCCCCCHHHHHHHHH
43.7125002506
26PhosphorylationSNSKSETTLEKLKGE
CCCCCHHHHHHHHHH
28.9425002506
27UbiquitinationNSKSETTLEKLKGEI
CCCCHHHHHHHHHHH
7.7321890473
29UbiquitinationKSETTLEKLKGEIAH
CCHHHHHHHHHHHHH
59.6233845483
31UbiquitinationETTLEKLKGEIAHLK
HHHHHHHHHHHHHHH
66.6121906983
31 (in isoform 1)Ubiquitination-66.6121890473
31 (in isoform 2)Ubiquitination-66.6121890473
32UbiquitinationTTLEKLKGEIAHLKT
HHHHHHHHHHHHHHC
41.8122817900
38UbiquitinationKGEIAHLKTSVDEIT
HHHHHHHHCCHHHHH
28.9629967540
39PhosphorylationGEIAHLKTSVDEITS
HHHHHHHCCHHHHHC
40.1023312004
40PhosphorylationEIAHLKTSVDEITSG
HHHHHHCCHHHHHCC
26.4523312004
45PhosphorylationKTSVDEITSGKGKLT
HCCHHHHHCCCCCCC
29.4027470641
48AcetylationVDEITSGKGKLTDKE
HHHHHCCCCCCCHHH
53.2726051181
48UbiquitinationVDEITSGKGKLTDKE
HHHHHCCCCCCCHHH
53.2732015554
52PhosphorylationTSGKGKLTDKERHRL
HCCCCCCCHHHHHHH
48.81-
64UbiquitinationHRLLEKIRVLEAEKE
HHHHHHHHHHHHHHH
37.7322817900
66UbiquitinationLLEKIRVLEAEKEKN
HHHHHHHHHHHHHHC
3.5622817900
72UbiquitinationVLEAEKEKNAYQLTE
HHHHHHHHCHHHCCH
58.9333845483
75PhosphorylationAEKEKNAYQLTEKDK
HHHHHCHHHCCHHHH
17.2828060719
92UbiquitinationQRLRDQLKARYSTTT
HHHHHHHHHHHHHHH
25.78-
95PhosphorylationRDQLKARYSTTTLLE
HHHHHHHHHHHHHHH
18.4130576142
96PhosphorylationDQLKARYSTTTLLEQ
HHHHHHHHHHHHHHH
17.4524719451
97PhosphorylationQLKARYSTTTLLEQL
HHHHHHHHHHHHHHH
18.1827251275
98PhosphorylationLKARYSTTTLLEQLE
HHHHHHHHHHHHHHH
14.9830576142
99PhosphorylationKARYSTTTLLEQLEE
HHHHHHHHHHHHHHH
29.4530576142
119UbiquitinationERREQVLKALSEEKD
HHHHHHHHHHHHCHH
48.7229967540
125UbiquitinationLKALSEEKDVLKQQL
HHHHHHCHHHHHHHH
49.4322817900
129UbiquitinationSEEKDVLKQQLSAAT
HHCHHHHHHHHHHHH
35.53-
129UbiquitinationSEEKDVLKQQLSAAT
HHCHHHHHHHHHHHH
35.5322817900
129 (in isoform 1)Ubiquitination-35.5321890473
129 (in isoform 2)Ubiquitination-35.5321890473
133PhosphorylationDVLKQQLSAATSRIA
HHHHHHHHHHHHHHH
16.1229514088
136PhosphorylationKQQLSAATSRIAELE
HHHHHHHHHHHHHHH
20.4629514088
137PhosphorylationQQLSAATSRIAELES
HHHHHHHHHHHHHHH
19.5729514088
144PhosphorylationSRIAELESKTNTLRL
HHHHHHHHHCCCEEH
58.3629514088
145UbiquitinationRIAELESKTNTLRLS
HHHHHHHHCCCEEHH
36.10-
145UbiquitinationRIAELESKTNTLRLS
HHHHHHHHCCCEEHH
36.1022817900
145 (in isoform 1)Ubiquitination-36.1021890473
145 (in isoform 2)Ubiquitination-36.1021890473
146PhosphorylationIAELESKTNTLRLSQ
HHHHHHHCCCEEHHC
42.59-
148PhosphorylationELESKTNTLRLSQTV
HHHHHCCCEEHHCCC
20.63-
152PhosphorylationKTNTLRLSQTVAPNC
HCCCEEHHCCCCCCC
19.8527080861
154PhosphorylationNTLRLSQTVAPNCFN
CCEEHHCCCCCCCCC
18.4325159151
162PhosphorylationVAPNCFNSSINNIHE
CCCCCCCCCCCCHHE
16.6127080861
163PhosphorylationAPNCFNSSINNIHEM
CCCCCCCCCCCHHEE
30.3627080861
175UbiquitinationHEMEIQLKDALEKNQ
HEEEEHHHHHHHHHC
25.2822817900
180UbiquitinationQLKDALEKNQQWLVY
HHHHHHHHHCCEEEE
61.99-
180UbiquitinationQLKDALEKNQQWLVY
HHHHHHHHHCCEEEE
61.9922817900
180 (in isoform 1)Ubiquitination-61.9921890473
180 (in isoform 2)Ubiquitination-61.9921890473
187PhosphorylationKNQQWLVYDQQREVY
HHCCEEEEHHHHHHH
13.0827642862
196UbiquitinationQQREVYVKGLLAKIF
HHHHHHHHHHHHHHH
26.59-
196UbiquitinationQQREVYVKGLLAKIF
HHHHHHHHHHHHHHH
26.5921890473
196 (in isoform 1)Ubiquitination-26.5921890473
196 (in isoform 2)Ubiquitination-26.5921890473
198UbiquitinationREVYVKGLLAKIFEL
HHHHHHHHHHHHHHH
3.3122505724
201UbiquitinationYVKGLLAKIFELEKK
HHHHHHHHHHHHHHH
48.1521906983
201 (in isoform 1)Ubiquitination-48.1521890473
201 (in isoform 2)Ubiquitination-48.1521890473
2072-HydroxyisobutyrylationAKIFELEKKTETAAH
HHHHHHHHHHHHHHH
77.08-
207UbiquitinationAKIFELEKKTETAAH
HHHHHHHHHHHHHHH
77.0832015554
208UbiquitinationKIFELEKKTETAAHS
HHHHHHHHHHHHHHC
42.0729967540
215PhosphorylationKTETAAHSLPQQTKK
HHHHHHHCCCCCCCC
36.7030576142
220PhosphorylationAHSLPQQTKKPESEG
HHCCCCCCCCCCCCC
35.4730576142
221UbiquitinationHSLPQQTKKPESEGY
HCCCCCCCCCCCCCC
63.0932015554
222UbiquitinationSLPQQTKKPESEGYL
CCCCCCCCCCCCCCC
58.3632015554
225PhosphorylationQQTKKPESEGYLQEE
CCCCCCCCCCCCHHH
44.8628851738
228PhosphorylationKKPESEGYLQEEKQK
CCCCCCCCCHHHHHH
10.9329978859
229UbiquitinationKPESEGYLQEEKQKC
CCCCCCCCHHHHHHH
8.3222817900
233AcetylationEGYLQEEKQKCYNDL
CCCCHHHHHHHHHHH
55.0626051181
233UbiquitinationEGYLQEEKQKCYNDL
CCCCHHHHHHHHHHH
55.0621906983
233 (in isoform 1)Ubiquitination-55.0621890473
233 (in isoform 2)Ubiquitination-55.0621890473
235UbiquitinationYLQEEKQKCYNDLLA
CCHHHHHHHHHHHHH
50.1622817900
237PhosphorylationQEEKQKCYNDLLASA
HHHHHHHHHHHHHHH
20.8127642862
243PhosphorylationCYNDLLASAKKDLEV
HHHHHHHHHHHCHHH
40.3621815630
245UbiquitinationNDLLASAKKDLEVER
HHHHHHHHHCHHHHH
44.3032015554
246UbiquitinationDLLASAKKDLEVERQ
HHHHHHHHCHHHHHH
68.23-
268UbiquitinationELSEFRRKYEETQKE
HHHHHHHHHHHHHHH
53.4029967540
269PhosphorylationLSEFRRKYEETQKEV
HHHHHHHHHHHHHHH
19.7223403867
272PhosphorylationFRRKYEETQKEVHNL
HHHHHHHHHHHHHHH
32.7623403867
274UbiquitinationRKYEETQKEVHNLNQ
HHHHHHHHHHHHHHH
69.9529967540
284PhosphorylationHNLNQLLYSQRRADV
HHHHHHHHHHHHHHH
16.0229978859
285PhosphorylationNLNQLLYSQRRADVQ
HHHHHHHHHHHHHHH
19.7229978859
300UbiquitinationHLEDDRHKTEKIQKL
HHHCCHHHHHHHHHH
60.3129967540
303UbiquitinationDDRHKTEKIQKLREE
CCHHHHHHHHHHHHH
56.5229967540
306UbiquitinationHKTEKIQKLREENDI
HHHHHHHHHHHHCCH
53.6529967540
317UbiquitinationENDIARGKLEEEKKR
HCCHHHCHHHHHHHH
47.3629967540
336PhosphorylationLSQVQFLYTSLLKQQ
HHHHHHHHHHHHHHH
8.7922461510
337PhosphorylationSQVQFLYTSLLKQQE
HHHHHHHHHHHHHHH
18.2922461510
338PhosphorylationQVQFLYTSLLKQQEE
HHHHHHHHHHHHHHH
20.3924719451
341UbiquitinationFLYTSLLKQQEEQTR
HHHHHHHHHHHHHHH
56.05-
360PhosphorylationEQQMQACTLDFENEK
HHHHHHHCCCCCCCH
32.17-
367UbiquitinationTLDFENEKLDRQHVQ
CCCCCCCHHHHHHHH
68.2332015554
396PhosphorylationNQITQLESLKQLHEF
HHHHHHHHHHHHHHH
49.8427067055
398UbiquitinationITQLESLKQLHEFAI
HHHHHHHHHHHHHHC
61.1622817900
398 (in isoform 1)Ubiquitination-61.1621890473
425PhosphorylationNREKVAASPKSPTAA
CHHHHCCCCCCCCHH
24.1125159151
427UbiquitinationEKVAASPKSPTAALN
HHHCCCCCCCCHHHC
67.5829967540
428PhosphorylationKVAASPKSPTAALNE
HHCCCCCCCCHHHCH
30.7619664994
430PhosphorylationAASPKSPTAALNESL
CCCCCCCCHHHCHHH
31.4922167270
436PhosphorylationPTAALNESLVECPKC
CCHHHCHHHCCCCCC
36.3219664994
442UbiquitinationESLVECPKCNIQYPA
HHHCCCCCCCCCCCC
52.1229967540
461PhosphorylationDLLVHVEYCSK----
CEEEEHHCCCC----
10.8429978859
463PhosphorylationLVHVEYCSK------
EEEHHCCCC------
40.2629978859

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
425SPhosphorylationKinaseCDK1P06493
Uniprot
425SPhosphorylationKinaseERK2P28482
PSP
428SPhosphorylationKinaseCDK1P06493
Uniprot
428SPhosphorylationKinaseERK2P28482
PSP
436SPhosphorylationKinasePLK1P53350
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
425SPhosphorylation

16198290
425SPhosphorylation

16198290
425SPhosphorylation

16198290
428SPhosphorylation

16198290
428SPhosphorylation

16198290
428SPhosphorylation

16198290
436SPhosphorylation

16198290
436SPhosphorylation

16198290

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CEP55_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TS101_HUMANTSG101physical
17853893
VP37B_HUMANVPS37Bphysical
17853893
VP37C_HUMANVPS37Cphysical
17853893
PDC6I_HUMANPDCD6IPphysical
17853893
TS101_HUMANTSG101physical
17556548
PDC6I_HUMANPDCD6IPphysical
17556548
CEP55_HUMANCEP55physical
17556548
PDC6I_HUMANPDCD6IPphysical
18948538
TS101_HUMANTSG101physical
18948538
NBR1_HUMANNBR1physical
21909099
CEP55_HUMANCEP55physical
25416956
PKHG6_HUMANPLEKHG6physical
25416956
RBM22_HUMANRBM22physical
25416956
RCOR3_HUMANRCOR3physical
25416956
EIF1A_HUMANEIF1ADphysical
25416956
MUM1_HUMANMUM1physical
25416956
SPF45_HUMANRBM17physical
25416956
FBF1_HUMANFBF1physical
25416956
MISSL_HUMANMAPK1IP1Lphysical
25416956
HAUS1_HUMANHAUS1physical
25416956
ADIP_HUMANSSX2IPphysical
25416956
CCBE1_HUMANCCBE1physical
25416956
CE57L_HUMANCEP57L1physical
25416956
TGO1_HUMANMIA3physical
25416956
PEF1_HUMANPEF1physical
25416956
TEAD4_HUMANTEAD4physical
21516116
MTMR4_HUMANMTMR4physical
27432908

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CEP55_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-425; SER-428; THR-430AND SER-436, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-425; SER-428; THR-430AND SER-436, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-425 AND SER-428, ANDMASS SPECTROMETRY.
"Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosomeprotein, Cep55, is required for its recruitment to midbody andcytokinesis.";
Fabbro M., Zhou B.-B., Takahashi M., Sarcevic B., Lal P., Graham M.E.,Gabrielli B.G., Robinson P.J., Nigg E.A., Ono Y., Khanna K.K.;
Dev. Cell 9:477-488(2005).
Cited for: FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INTERACTION WITHPLK1; AKAP9 AND PCNT, PHOSPHORYLATION AT SER-425; SER-428 AND SER-436,MUTAGENESIS OF SER-396; SER-425; SER-428 AND SER-436, AND MASSSPECTROMETRY.

TOP